Click on the project title for detailed information including publications and presentations.

Stuart, B. (PI), and Terza, J. "Medicare Beneficiary Response to Benefit Gaps Versus Actuarially Equivalent Continuous Coverage for Prescription Drugs." The Robert Wood Johnson Foundation, HCFO (2006-2007) $153,762.

Stuart, B. (PI), and Simoni-Wastila, L. "Chartbook on Medication Use by Aged and Disabled Medicare Beneficiaries across the Spectrum of Morbidity." The Commonwealth Fund #20060457 (2006-2007) $41,141.

Stuart, B. (PI), Simoni-Wastila, L., and Shea, D., "Benchmarking the Quality of Medication Use by Medicare Beneficiaries," The Commonwealth Fund, $269,694 (2005-2007)

Stuart, B. (PI), Simoni-Wastila, L. (Co-I), Zuckerman, I.H. (Co-I) "Benchmarking the Quality of Medication Use by Medicare Beneficiaries," The Commonwealth Fund, #20050634, $269,694 (8/1/2005 - 1/31/2007).

Simoni-Wastila, L. (PI) "Prescription Drug Spending by Medicare Beneficiaries in Institutional and Residential Settings," Assistant Secretary for Planning and Evaluation, DHHS, HHSP23320044, $399,865 (9/30/04 - 9/29/06).

Stuart, B. (PI), Briesacher, B., and Simoni-Wastila, L., “Establishing the Value of Stable Prescription Coverage for Medicare Beneficiaries,” The Robert Wood Johnson Foundation, HCFO P402, $291,039 (2004-2005).

Stuart, B. (PI), Briesacher, B., and Shea, D. “Evaluation of the Effect of Medicare Drug Policy Decisions on Vulnerable Seniors,” The Commonwealth Fund, No. 20040184, $278,757 (2004-2005).  http://www.cmwf.org/grants/grantdetail.asp?id=1000&pid=2&link=5

Zuckerman, I. (PI) "Predicting Transitions Among Community-Dwelling Elders," National Institute of Aging. K01-AG022011-01A1. $598,750 (4/1/2004 – 3/31/2009)

Simoni-Wastila, L (PI), "Massachusetts Medicaid Infrastructure Grant: Patterns of Psychoactive Drug Use and Impact on Medical Services Utilization and Productivity Among Medicaid Mentally Disabled Recipients," University of Massachusetts Medical School 6035393/RFS100, $48,926 (2004).

Simoni-Wastila, L. (PI), "Evaluation of Antipsychotic Use in Long-Term Care Facilities," West Virginia Medical Institute/CMS CMS-03-00321, $100,000 (2003 - 2004).

Stuart, B. (PI), "Analysis of the Stability of Medicaid Coverage for Dual Eligible Medicare Beneficiaries," Kaiser Family Foundation 01-1144-450, $20,000 (2003 - 2004).

Zuckerman, I. (PI), "Pennsylvania Medicaid Retrospective Drug Utilization Review Program," Pennsylvania Department of Public Welfare 4100011377, $1,292,398
(4/03 - 6/04).

Zuckerman, I. (PI on subcontract), "Center for Minority Health Services Research," Howard University 1R24HS11673 / 632086-H003108 - subcontract to the University of Maryland Baltimore, $138,094 (9/02 - 9/05).

Simoni-Wastila, L (PI), "Impact of 3-Tier Copays on Use and Spending," Agency for Healthcare Research and Quality with Brandeis University R01 H513092, $1,141,542 (2002 – 2005).

Simoni-Wastila, L (PI), "Potentially Problematic Drug Use in the Elderly," Johnson, Bassin and Shaw/Substance Abuse and Mental Health Services Administration 277996031, $38,000 (2002 - 2003).

Briesacher, B. (PI), "Evaluation of Drug Therapy Guidelines to Reduce the Use of Potentially Inappropriate Drug Use in Nursing Homes," West Virginia Medical Institute, $100,849, (2002-2003).

Stuart, B. (PI), "Impact of Prescription Drug Coverage on Medicare Program Expenditures-A Case Study of the UMWA," Centers for Medicare and Medicaid Services, 500-00-0032, $114,000, subcontract amount to the University of Maryland.  (2002-2003).

Stuart, B. (PI), "Prescription Drug Use among Institutionalized Medicare Beneficiaries," West Virginia Medical Institute/CMS $100,000 (2002).

Simoni-Wastila, L (PI), "Prescription Drug Policy and Evaluation," University of Massachusetts Medical School $88,486 (2001 - present).
                                         
Stuart, B. (PI), Shea, D., Briesacher, B., Zuckerman, I., "Addressing the Cost and Quality of Prescription Coverage of Medicare Beneficiaries," The Commonwealth Fund, $276,856 (2001-2003).

Briesacher, B. (PI), "What Effect Do Tiered Drug Plans Have on NSAID Use," Novartis Pharmaceutical Corporation, $11,072 (2002).

Briesacher, B. (PI), and Stuart, B. (Co-PI), "The Influence of Benefit Design Features on Drug Selection Decisions and Spending," Novartis Pharmaceuticals Corporation, $37,975 (2001-2002).

Stuart, B (PI) and others "Utilization and Access to Prescription Drugs for People with Disabilities," DHHS, Assistant Secretary for Planning and Evaluation. Office of Disability, Aging, and Long Term Care. Contract No. 25-01-HHS-OS, $153,106,  (2001-2002).

Briesacher, B (PI), Stuart, B. (Co-PI), "Evaluation of Fracture Risk in a Skilled Nursing Facility Population," Omnicare, Inc., $42,227 (2001-2002).

Stuart, B. (PI), Palumbo, F., Briesacher, B. "Innovative Approaches to Controlling Medicaid Prescription Drug Cost," AARP Public Policy Institute, $30,000 (2001-2002). 
Stuart, B. (PI) "Coverage, Access, and Use of Prescription Drugs by Disabled Medicare Beneficiaries." Co-funded by the Commonwealth Fund and the Kaiser Family Foundation, $29,070 (2001-2002).